Toward the total synthesis of spirastrellolide A. Part 2: Conquest of the northern hemisphere

Angewandte Chemie - International Edition

Volumn 45, Issue 33, 2006, Pages 5510-5515

  Fürstner, Alois ^a   Fenster, Michaël D B ^a   Fasching, Bernhard ^a   Godbout, Cédrickx ^a   Radkowski, Karin ^a  

^a MAX PLANCK INSTITUT FÜR KOHLENFORSCHUNG   (Germany)

Author keywords

Cycloaddition; Macrolides; Natural products; Phosphatase inhibitors; Total synthesis

Indexed keywords

ANTINEOPLASTIC AGENT; MACROLIDE; SPIRASTRELLOLIDE A;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; METABOLISM; SPONGE (PORIFERA); SYNTHESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; MACROLIDES; MOLECULAR STRUCTURE; PORIFERA;

EID: 33748636245     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200601655     Document Type: Article

References (50)

1. a) D. E. Williams, M. Lapawa, X. Feng, T. Tarling, M. Roberge, R. J. Andersen, Org. Lett. 2004, 6, 2607-2610;
2. b) D. E. Williams, M. Roberge, R. Van Soest, R. J. Andersen, J. Am. Chem. Soc. 2003, 125, 5296-5297.
3. For previous syntheses and biological evaluations of phosphatase inhibitors from this group, see: a) A. Fürstner, F. Feyen, H. Prinz, H. Waldmann, Angew. Chem. 2003, 115, 5519-5522;
4. Angew. Chem. Int. Ed. 2003, 42, 5361-5364;
5. b) A. Fürstner, F. Feyen, H. Prinz, H. Waldmann, Tetrahedron 2004, 60, 9543-9558;
6. c) A. Fürstner, J. Ruiz-Caro, H. Prinz, H. Waldmann, J. Org. Chem. 2004, 69, 459-467;
7. d) A. Fürstner, K. Reinecke, H. Prinz, H. Waldmann, ChemBioChem 2004, 5, 1575-1579;
8. e) M. Manger, M. Scheck, H. Prinz, J. P. von Kries, T. Langer, K. Saxena, H. Schwalbe, A. Fürstner, J. Rademann, H. Waldmaan, ChemBioChem 2005, 6, 1749-1753.
9. A. Fürstner, M. D. B. Fenster, B. Fasching, C. Godbout, K. Radkowski, Angew. Chem. 2006, 118, 5632-5636;
10. Angew. Chem. Int. Ed. 2006, 45, 5506-5510.
11. The only other synthesis of the [5,6,6]-bis-spirocyclic entity of 1: I. Paterson, E. A. Anderson, S. M. Dalby, O. Loiseleur, Org. Lett. 2005, 7, 4121-4224.
12. a) M. D. Chappell, S. J. Stachel, C. B. Lee, S. J. Danishefsky, Org. Lett. 2000, 2, 1633-1636;
13. b) M. T. Crimmins, K. A. Emmitte, J. D. Katz, Org. Lett. 2000, 2, 2165-2167.
14. Prepared according to literature precedence: a) S. Ma, X. Lu, Z. Li, J. Org. Chem. 1992, 57, 709-713;
15. b) E. Piers, J. Renaud, S. J. Rettig, Synthesis 1998, 590-602;
16. c) A. Toró, P. Nowak, P. Deslongchamps, J. Am. Chem. Soc. 2000, 122, 4526-4527.
17. D. A. Evans, M. M. Morrissey, R. L. Dorow, J. Am. Chem. Soc. 1985, 107, 4346-4348; good results were obtained only when the reaction was performed at 50°C; otherwise, a competing attack of MeOMgBr at the carbamate carbonyl group of the substrate is observed, which lowers the yield of 6.
18. a) W. J. Scott, J. K. Stille, J. Am. Chem. Soc. 1986, 108, 3033-3040;
19. b) W. D. Wulff, G. A. Peterson, W. E. Bauta, K.-S. Chan, K. L. Faron, S. R. Gilbertson, R. W. Kaesler, D. C. Young, C. K. Murray, J. Org. Chem. 1986, 51, 277-279;
20. c) C. D. Vanderwal, D. A. Vosburg, E. J. Sorensen, Org. Lett. 2001, 3, 4307-4310.
21. Review on bis-spiroacetal formations: M. A. Brimble, F. A. Farès, Tetrahedron 1999, 55, 7661-7706.
22. Details will be reported in a forthcoming full paper.
23. a) A. Guarna, A. Guidi, A. Goti, A. Brandi, F. De Sarlo, Synthesis 1989, 175-178;
24. b) P. G. Baraldi, A. Barco, S. Benetti, S. Manfredini, D. Simoni, Synthesis 1987, 276-278.
25. J. W. Bode, E. M. Carreira, J. Org. Chem. 2001, 66, 6410-6424.
26. M. J. Mintz, C. Walling, Org. Synth. 1969, 49, 9-12.
27. Reviews on the use of 2-isoxazolines as aldol surrogates: a) D. P. Curran, Adv. Cycloaddit. 1988, 1, 129-189;
28. b) S. Kanemasa, O. Tsuge, Heterocycles 1990, 30, 719-736.
29. a) S. Kanemasa, M. Nishiuchi, A. Kamimura, K. Hori, J. Am. Chem. Soc. 1994, 116, 2324-2339;
30. b) for an optimization and elegant application, see: J. W. Bode, N. Fraefel, D. Muri, E. M. Carreira, Angew. Chem. 2001, 113, 2128-2131;
31. Angew. Chem. Int. Ed. 2001, 40, 2082-2085.
32. S. E. Schaus, B. D. Brandes, J. F. Larrow, M. Tokunaga, K. B. Hansen, A. E. Gould, M. E. Furrow, E. N. Jacobsen, J. Am. Chem. Soc. 2002, 124, 1307-1315.
33. L. Alcaraz, J. J. Harnett, C. Mioskowski, J. P. Martel, T. Le Gall, D.-S. Shin, J. R. Falck, Tetrahedron Lett. 1994, 35, 5449-5452.
34. a) S. Hu, S. Jayaraman, A. C. Oehlschlager, J. Org. Chem. 1998, 63, 8843-8849;
35. b) S. Hu, S. Jayaraman, A. C. Oehlschlager, J. Org. Chem. 1996, 61, 7513-7520.
36. U. S. Racherla, H. C. Brown, J. Org. Chem. 1991, 56, 401-404.
37. H. C. Kolb, M. S. VanNieuwenhze, K. B. Sharpless, Chem. Rev. 1994, 94, 2483-2547.
38. A. B. Smith, C. M. Adams, Acc. Chem. Res. 2004, 37, 365-377.
39. a) G. Stork, L. Maldonado, J. Am. Chem. Soc. 1971, 93, 5286-5287;
40. b) G. Stork, L. Maldonado, J. Am. Chem. Soc. 1974, 96, 5272-5274;
41. c) for applications in natural product synthesis, see: T. Takahashi, H. Nemoto, Y. Kanda, J. Tsuji, Y. Fukazawa, T. Okajima, Y. Fujise, Tetrahedron 1987, 43, 5499-5520;
42. d) H. Takayanagi, Y. Kitano, Y. Morinaka, J. Org. Chem. 1994, 59, 2700-2706;
43. e) A. B. Smith, C. Sfouggatakis, D. B. Gotchev, S. Shirakami, D. Bauer, W. Zhu, V. A. Doughty, Org. Lett. 2004, 6, 3637-3640.
44. S. S. Kim, G. Rajogopal, D. W. Kim, D. H. Song, Synth. Commun. 2004, 34, 2973-2980.
45. The time for deprotonation must be <5 minutes; otherwise, significant decomposition of the cyanohydrin part was observed. Likewise, the use of KHMDS as the base and hexamethyl phosphoramide (HMPA) as a cosolvent were detrimental.
46. The configuration of the cyanohydrin center C31 has not been determined.
47. a) K. A. Scheidt, H. Chen, B. C. Follows, S. R. Chemler, D. S. Coffey, W. R. Roush, J. Org. Chem. 1998, 63, 6436-6437;
48. b) R. Noyori, I. Nishida, J. Sakata, J. Am. Chem. Soc. 1983, 105, 1598-1608;
49. c) recent application: C. Aïssa, R. Riveiros, J. Ragot, A. Fürstner, J. Am. Chem. Soc. 2003, 125, 15 512-15 520.
50. NMR spectroscopic analysis suggests that the compound mainly exists as a pyranoid hemiacetal analogous to that found in 35.